HT001419C0006 · ADAPTIVE BIOTECHNOLOGIES CORPORATION
USAspending.gov·2026-07-30·CONT_AWD_HT001419C0006_9700_-NONE-_-NONE-
ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $385,920 from Defense Health Agency. CLONOSEQ MINIMAL RESIDUAL DISEASE IN-VITRO DIAGNOSTIC ARRAY FOR THE DEPARTMENT OF PATHOLOGY AT WALTER REED NATIONAL MILITARY MEDICAL CENTER
A · 官方确认方向已确认